BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
- Status
- RECRUITING
- Phase
- PHASE1
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)
- Status
- RECRUITING
- Phase
- NA
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
- Status
- RECRUITING
- Phase
- NA
Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
- Status
- RECRUITING
- Phase
- PHASE3
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
- Status
- RECRUITING
- Phase
- PHASE4